# Safety and Efficacy of Varicella Zoster Immune Globulin (Human) VariZIG in Patients at Risk of Varicella Infection

> **NCT00338442** · — · APPROVED_FOR_MARKETING · sponsor: **Cangene Corporation**

## Conditions studied

- Varicella

## Interventions

- **DRUG:** VariZIG™

## Key facts

- **NCT ID:** NCT00338442
- **Lead sponsor:** Cangene Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** APPROVED_FOR_MARKETING
- **Start date:** 2006-02
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** — (—)
- **Last updated:** 2013-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00338442

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00338442, "Safety and Efficacy of Varicella Zoster Immune Globulin (Human) VariZIG in Patients at Risk of Varicella Infection". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00338442. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*